Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT00864110 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

RADIATION: Radiolabeled (99Tc) EC-DG (ethylenedicysteine-deoxyglucose)
RADIATION: Technetium 99m ethylenedicysteine-deoxyglucose
RADIATION: 18 F fluorodeoxyglucose

Sponsor

Cell>Point LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]